Arcturus Therapeutics Holdings Inc (ARCT)
18.30
+0.48
(+2.69%)
USD |
NASDAQ |
Nov 05, 16:00
18.30
0.00 (0.00%)
After-Hours: 19:18
Arcturus Therapeutics Holdings Free Cash Flow: -71.16M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -71.16M |
| March 31, 2024 | 9.765M |
| December 31, 2023 | -21.00M |
| September 30, 2023 | 136.96M |
| June 30, 2023 | 125.75M |
| March 31, 2023 | 38.86M |
| December 31, 2022 | 24.27M |
| September 30, 2022 | -175.80M |
| June 30, 2022 | -149.63M |
| March 31, 2022 | -146.53M |
| December 31, 2021 | -138.45M |
| September 30, 2021 | -102.16M |
| June 30, 2021 | -100.06M |
| March 31, 2021 | -75.67M |
| December 31, 2020 | -44.60M |
| September 30, 2020 | -45.13M |
| June 30, 2020 | -31.81M |
| March 31, 2020 | -13.77M |
| December 31, 2019 | -7.263M |
| September 30, 2019 | -5.398M |
| June 30, 2019 | -9.451M |
| March 31, 2019 | -27.00M |
| Date | Value |
|---|---|
| December 31, 2018 | -22.24M |
| September 30, 2018 | -11.40M |
| June 30, 2018 | -6.166M |
| March 31, 2018 | 3.531M |
| December 31, 2017 | -0.711M |
| September 30, 2017 | 6.14M |
| June 30, 2017 | 1.272M |
| March 31, 2017 | -4.054M |
| December 31, 2016 | -3.549M |
| September 30, 2016 | 6.754M |
| June 30, 2016 | 7.997M |
| March 31, 2016 | 8.19M |
| December 31, 2015 | 8.043M |
| September 30, 2015 | -21.70M |
| June 30, 2015 | -25.76M |
| March 31, 2015 | -27.33M |
| December 31, 2014 | -28.40M |
| September 30, 2014 | -25.51M |
| June 30, 2014 | -18.02M |
| March 31, 2014 | -12.89M |
| December 31, 2013 | -7.353M |
Free Cash Flow Range, Past 5 Years
-175.80M
Minimum
Sep 2022
136.96M
Maximum
Sep 2023
-41.44M
Average
-44.60M
Median
Dec 2020
Free Cash Flow Benchmarks
| Fulcrum Therapeutics Inc | -12.62M |
| Bioventus Inc | 8.443M |
| Semler Scientific Inc | -40.11M |
| Liquidia Corp | -87.66M |
| Pfizer Inc | 4.81B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -30.14M |
| Cash from Investing (Quarterly) | -0.328M |
| Cash from Financing (Quarterly) | 2.403M |
| Free Cash Flow Per Share (Quarterly) | -1.130 |
| Free Cash Flow to Equity (Quarterly) | -30.47M |
| Free Cash Flow to Firm (Quarterly) | -30.47M |
| Free Cash Flow Yield | -14.50% |